VDAC1 Inhibition Mitigates Inflammatory Status and Oxidative Stress in Epileptic Mice Treated with the Ketogenic Diet

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Ketogenic diet (KD) shows pleiotropic effects on inflammation and oxidative stress, making it a potential epilepsy management strategy.
• Voltage-dependent anion channel 1 (VDAC1) is implicated in inflammatory and oxidative stress pathways.
• The interplay between KD, VDAC1, and epilepsy remains unclear.

Purpose of the Study:

• To investigate the role of VDAC1 in the anti-seizure effects of the ketogenic diet.
• To examine the impact of a VDAC1 antagonist (VBIT-4) on seizure activity, behavior, inflammation, and oxidative stress in an epilepsy model under control diet (CD) and KD.

Main Methods:

• Utilized a pilocarpine-induced chronic epilepsy mouse model.
• Administered VDAC1 antagonist VBIT-4 under both control diet (CD) and ketogenic diet (KD) conditions.
• Assessed seizure activity, behavioral changes, hippocampal and serum inflammation, and oxidative stress markers.

Main Results:

• Chronic VBIT-4 treatment significantly mitigated seizure activity and behavioral abnormalities in epileptic mice on KD, but not on CD.
• VDAC1 antagonist treatment attenuated inflammatory responses and oxidative stress in hippocampi and serum from epileptic mice on KD.
• These effects were not observed in mice on the control diet.

Conclusions:

• VDAC1 plays a crucial role in mediating the anti-seizure efficacy of the ketogenic diet.
• Targeting VDAC1 in conjunction with KD may offer novel therapeutic strategies for epilepsy.
• This research provides insights into the molecular mechanisms underlying KD's benefits in epilepsy.